This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Domain Therapeutics. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ismet Dorange: Innovator in Prostaglandin Research
Introduction
Ismet Dorange is a notable inventor based in Illkirch-Graffenstaden, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific receptors involved in various diseases.
Latest Patents
Dorange holds a patent for Prostaglandin E(PGE) EPreceptor antagonists. This invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, making them highly advantageous for therapeutic use. They are particularly relevant in the treatment or prevention of cancer, neovascular eye diseases, inflammatory pain, and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, or endometriosis.
Career Highlights
Ismet Dorange is associated with Domain Therapeutics, where he continues to advance research in the pharmaceutical sector. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Dorange collaborates with esteemed colleagues, including Stanislas Mayer and Gaël Hommet, to further enhance the impact of his research and inventions.
Conclusion
Ismet Dorange's contributions to the field of prostaglandin research exemplify the importance of innovation in developing new therapeutic options. His work not only highlights his expertise but also the collaborative efforts that drive advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile